Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NCT03570619 error page was replaced by the complete study record, with details on the trial design, eligibility, locations, outcomes, and study documents.
    Difference
    57%
    Check dated 2026-11-07T11:44:09.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T12:12:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:06:23.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T12:32:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:42:46.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details. This indicates restricted access to the record and replaces the usual content with an error screen.
    Difference
    19%
    Check dated 2026-09-19T22:05:24.000Z thumbnail image

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.